DOCSLIB.ORG

The Pharmacologist 2 0 0 6 December

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Pharmacologist 2 0 0 6 December Vol. 48 Number 4 The Pharmacologist 2 0 0 6 December 2006 YEAR IN REVIEW The Presidential Torch is passed from James E. Experimental Biology 2006 in San Francisco Barrett to Elaine Sanders-Bush ASPET Members attend the 15th World Congress in China Young Scientists at EB 2006 ASPET Awards Winners at EB 2006 Inside this Issue: ASPET Election Online EB ’07 Program Grid Neuropharmacology Division Mixer at SFN 2006 New England Chapter Meeting Summary SEPS Meeting Summary and Abstracts MAPS Meeting Summary and Abstracts Call for Late-Breaking Abstracts for EB‘07 A Publication of the American Society for 121 Pharmacology and Experimental Therapeutics - ASPET Volume 48 Number 4, 2006 The Pharmacologist is published and distributed by the American Society for Pharmacology and Experimental Therapeutics. The Editor PHARMACOLOGIST Suzie Thompson EDITORIAL ADVISORY BOARD Bryan F. Cox, Ph.D. News Ronald N. Hines, Ph.D. Terrence J. Monks, Ph.D. 2006 Year in Review page 123 COUNCIL . President Contributors for 2006 . page 124 Elaine Sanders-Bush, Ph.D. Election 2007 . President-Elect page 126 Kenneth P. Minneman, Ph.D. EB 2007 Program Grid . page 130 Past President James E. Barrett, Ph.D. Features Secretary/Treasurer Lynn Wecker, Ph.D. Secretary/Treasurer-Elect Journals . Annette E. Fleckenstein, Ph.D. page 132 Past Secretary/Treasurer Public Affairs & Government Relations . page 134 Patricia K. Sonsalla, Ph.D. Division News Councilors Bryan F. Cox, Ph.D. Division for Neuropharmacology . page 136 Ronald N. Hines, Ph.D. Centennial Update . Terrence J. Monks, Ph.D. page 137 Chair, Board of Publications Trustees Members in the News . page 138 Brian M. Cox, Ph.D. Staff News . Chair, Program Committee page 138 Jack Bergman, Ph.D. New ASPET Members . page 139 FASEB Board Representative Obituary – Wilber Marvin Davis . David B. Bylund page 143 Chair, Long Range Planning Committee Obituary – William Berndt . page 144 Stephen G. Holtzman Obituary – Robert George . Executive Officer page 145 Christine K. Carrico, Ph.D. Death Notices . page 146 Chapter News The Pharmacologist (ISSN 0031-7004) is published quarterly in March, June, New England Pharmacologists Meeting Summary . page 147 September, and December by the Southeastern Pharmacology Meeting and Abstracts . page 149 American Society for Pharmacology and Mid-Atlantic Pharmacology Meeting and Abstracts . Experimental Therapeutics, 9650 page 165 Rockville Pike, Bethesda, MD 20814- 3995. Annual subscription rates: $20.00 for ASPET Members; $45.00 for Announcements U.S. nonmembers and institutions; $65.00 for nonmembers and institutions outside the U.S. Single copy: $20.00. Call for Late Breaking Abstracts (EB 2007) . page 176 Copyright © 2006 by the American Society for Pharmacology and GPCR Colloquium Information and Registration . page 177 Experimental Therapeutics, Inc. All Membership Information . page 178 rights reserved. Periodicals postage paid at Bethesda, MD. GST number for Membership Application . page 179 Canadian subscribers: BN:13489 2330 RT. ASPET assumes no responsibility for the statements and opinions advanced by contributors to The Pharmacologist. Reminder: Please pay your Deadlines for submission of material for publication: Issue 1, March 1; Issue 2, 2007 membership dues by June 1; Issue 3, September 1; and Issue 4, December 1. January 1, 2007. Postmaster: Send address changes to: The Pharmacologist , ASPET, 9650 Rockville Pike, Bethesda, MD 20814- 3995. A Publication of the American Society for 122 Pharmacology and Experimental Therapeutics - ASPET Volume 48 Number 4, 2006 YEAR IN REVIEW As 2006 comes to a close, ASPET would like to thank you for your participation in the Society this year. With the help of member contributions, support, and participation, we are pleased to announce the following accomplishments made by ASPET this year: Journals: This year our three primary research journals (JPET, DMD, and MolPharm) published 3% more articles over 2005. Also, in March, all archival issues of JPET back to volume 1, issue 1, went online, completing the online back-issue archive of ASPET’s journals. Molecular Interventions (our newest journal) is completing its sixth volume as 2006 comes to an end, and the Editorial Advisory Board is completing its first full year under John S. Lazo. Since John took on the job of Chair of the EAB, MI has instituted a new department (Nascent Transcripts) and has undergone the first rotations of EAB members. In the coming year, MI will rotate further new members onto the EAB and create a series of pieces to honor ASPET's upcoming Centennial celebration. Awards: In 2006, we awarded 79 travel awards to graduate students to attend EB and 20 travel awards to students to attend the IUPHAR Congress in Beijing, all supported by member and corporate donations. We also awarded 28 travel awards to Young Scientists to attend EB (funded out of the Young Scientist Travel Fund supported by member donations) and 7 to attend the IUPHAR Congress. Next year, we will be giving out two new awards, the ASPET-Astellas Awards and the Julius Axelrod Award. We are currently trying to establish an endowment for the Julius Axelrod Award. Membership: Our membership is also growing; this year we’ve recruited almost 500 new members, 350 of which are new student members. Next year, we hope to continue this growth and encourage more interest in pharmacology and the Society. Centennial Celebration: This year we have also begun preparations for ASPET’s 100th birthday in 2008. To celebrate we will begin rolling out some of our Centennial activities next year. This includes a historical perspective of pharmacology in Pharmacological Reviews, the Abel number, and other surprises. Public Affairs: ASPET continues its leading advocacy to increase training for integrative organ systems pharmacology. ASPET is also committed to making significant contributions through its new affiliation with The FDA Alliance to increase funding for the agency, and as always, we are continuing to work in partnerships with other biomedical research organizations on various science policy and funding issues concerning the National Institutes of Health. As we head into 2007, we plan to keep providing and improving the valued services you require. You can help us by making a contribution to one of the many funds that ASPET sets aside for special awards and events. Making a donation is a great way to demonstrate your commitment to the future of ASPET, pharmacology, and your profession. Please take the time to make a donation at http://www.aspet.org/public/membership/membership.html; click on “Make a Donation.” Thank you for your support for ASPET, and we look forward to making 2007 another successful year for pharmacology. A Publication of the American Society for 123 Pharmacology and Experimental Therapeutics - ASPET Volume 48 Number 4, 2006 CONTRIBUTORS FOR 2006 ASPET gratefully acknowledges the following individuals who have made contributions over and above dues for 2006: Eugene Herman Theodore Brody Julius Axelrod Award K. Roger Hornbrook Marlene Cohen Oliver Civelli David Jones James Fujimoto H. George Mandel Louis Lemberger Anthony Hance Michael O'Neill Steven Myers Robert Pechnick Jorge Perez-Cruet Gabrielle Reem Jorge Perez-Cruet Elaine Sanders-Bush Elaine Sanders-Bush Elaine Sanders-Bush Patricia Sonsalla Patricia Sonsalla Peter Syapin Richard Weinshilboum Ralph Tanz Theodore West Lynn Wecker Karl H. Beyer Student Travel Award Members Fund for Graduate Annette Beyer-Mears P.B. Dews Award Student Travel J. Frederick Pritchard Claire Advokat Donald Bogdanski Alexander Scriabine Jack Bergman Abby Collier Stanley Vickers Paul Draskoczy Martha Davila-Garcia Stephen Fowler Stewart Ehrreich B.B. Brodie Award Charles France Sakina Eltom Paul Hollenberg Louis Harris Ingeborg Hanbauer Roger Maickel Jonathan Katz K. Roger Hornbrook Yoichi Osawa Victor Laties Michelle Kalis Jorge Perez-Cruet James McKearney Hirochika Komai Gopal Rao Charles Schuster Elise Malecki I. Glenn Sipes Joseph Wettstein Michiko Okamoto Stanley Vickers James Woods George Okita Carol Paronis Joseph P. Buckley Student Travel Robert F. Furchgott Student Travel James Reese Fund Fund John Regan Balwant Dixit Donald Bennett M. Kent Shellenberger Morton Printz Richard Carchman Irwin Slater I. Glenn Sipes Walter Dixon Emel Songu-Mize Stewart Ehrreich Patricia Sonsalla Thomas F. Burks Student Travel Bruce Freeman Dhiren Thakker Fund Robert Furchgott Monica Valentovic Richard Bond Diana Krause Thomas Walle Anne Bonneville Suzanne Laychock Lynn Wecker David Brown Philip Merker Daniel Zaharko James Bruckner Odd Steinsland Reginald Butcher Young Scientist Travel Fund Peter Davies Harvey B. Haag Student Travel Fund Joe Beavo Julie Eiseman Allan Yard William Beck William Fleming Craig Beeson James Galligan Keshore Bidasee Joel Hardman IUPHAR Travel Fund Allan Blake Kenneth Johnson Richard Bond Terry Brown-Bryan Julian Moreton Margarita Dubocovich Oliver Civelli Mark Osinski John Fitzgerald Martha Davila-Garcia Kadhim Salman Jogananda Hazra Stewart Ehrreich Craig Stevens Dah Ho K. Roger Hornbrook Peter Syapin Beng Ho Thomas Kensler Frank Vincenzi Frederick Kauffman Yutaka Kobayashi Mark Voigt Diana Krause Brian Kobilka Paula Witt-Enderby Robert Stitzel Charles Nichol Achilles Pappano Centennial Fund Keith F. & Eva K. Killam Student Astrid Parenti Christine Carrico Travel Fund Kadhim Salman Gordon Coppoc Aisar Atrakchi Patricia Sonsalla William Fleming Anne Bonneville Lavern Weber Richard Hauger John Bowyer Lynn Wecker A Publication of the American
Load more

Recommended publications
  • Biologically Active Molecules from Soybeans
    10 Biologically Active Molecules from Soybeans Michio Kurosu Department of Pharmaceutical Sciences, University of Tennessee Health Science Center USA 1. Introduction Soybeans (Glycine max [L.] Merr.) contain an impressive array of biologically active components. People have been eating soybeans for almost 5,000 years. Unlike most plant foods, soybeans are high in protein. Researchers are interested in both the nutritional value and the potential health benefits of soybeans. Research of the health effects of soyfoods and soybean constituents has been received significant attention to support the health improvements or health risks observed clinically or in vitro experiments. This research includes a wide range of areas, such as cancer, coronary heart disease (cardiovascular disease), osteoporosis, cognitive function (memory related), menopausal symptoms, renal function, and many others. This chapter provides up-to-date coverage on biologically active and related organic molecules isolated from soy and soy products. Their biological activities are briefly summarized. Molecules discussed in this chapter are as follows: isoflavones, phytic acid, soy lipids, soy phytoalexins, soyasaponins, lectins, hemagglutinin, soy toxins, and vitamins. 2. Health benefit of soy or soy products Soy products have been considered as great source of protein for many decades. Japanese, in particular, eat a soy-based diet. Japanese monks eat soy products as their main protein source. They are known to live longer and have lower rates of chronic diseases. Because soybeans contain practically no starch, soybeans are an important part of a diabetic diet. Soybeans are 1) rich in protein (vide supra), calcium, and vitamins, and 2) high in mono- saturated fatty acids. In addition, soybeans contain several biologically interesting phytochemicals as minor components, which scientists are interested in understanding their biological functions.
    [Show full text]
  • You and AI Conversations About AI Technologies and Their Implications for Society
    You and AI Conversations about AI technologies and their implications for society SUPPORTED BY CONVERSATIONS ABOUT AI TECHNOLOGIES AND THEIR IMPLICATIONS FOR SOCIETY DeepMind1 2 CONVERSATIONS ABOUT AI TECHNOLOGIES AND THEIR IMPLICATIONS FOR SOCIETY You and AI Conversations about AI technologies and their implications for society Artificial Intelligence (AI) is the science of making computer systems smart, and an umbrella term for a range of technologies that carry out functions that typically require intelligence in humans. AI technologies already support many everyday products and services, and the power and reach of these technologies are advancing at pace. The Royal Society is working to support an environment of careful stewardship of AI technologies, so that their benefits can be brought into being safely and rapidly, and shared across society. In support of this aim, the Society’s You and AI series brought together leading AI researchers to contribute to a public conversation about advances in AI and their implications for society. CONVERSATIONS ABOUT AI TECHNOLOGIES AND THEIR IMPLICATIONS FOR SOCIETY 3 What AI can, and cannot, do The last decade has seen exciting developments in AI – and AI researchers are tackling some fundamental challenges to develop it further AI research seeks to understand what happens or inputs do not follow a standard intelligence is, and then recreate this through pattern, these systems cannot adapt their computer systems that can automatically rules or adjust their approach. perform tasks that require some level of reasoning or intelligence in humans. In the last decade, new methods that use learning algorithms have helped create In the past, AI research has concentrated computer systems that are more flexible on creating detailed rules for how to carry and adaptive, and Demis Hassabis FRS out a task and then developing computer (co-founder, DeepMind) has been at the systems that could carry out these rules; forefront of many of these developments.
    [Show full text]
  • Metabolomics and Transcriptomics Identify Multiple Downstream Targets of Paraburkholderia Phymatum Σ54 During Symbiosis with Phaseolus Vulgaris
    Research Collection Journal Article Metabolomics and Transcriptomics Identify Multiple Downstream Targets of Paraburkholderia phymatum σ54 During Symbiosis with Phaseolus vulgaris Author(s): Lardi, Martina; Liu, Yilei; Giudice, Gaetano; Ahrens, Christian H.; Zamboni, Nicola; Pessi, Gabriella Publication Date: 2018-04 Permanent Link: https://doi.org/10.3929/ethz-b-000258158 Originally published in: International Journal of Molecular Sciences 19(4), http://doi.org/10.3390/ijms19041049 Rights / License: Creative Commons Attribution 4.0 International This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library International Journal of Molecular Sciences Article Metabolomics and Transcriptomics Identify Multiple Downstream Targets of Paraburkholderia phymatum σ54 During Symbiosis with Phaseolus vulgaris Martina Lardi 1, Yilei Liu 1, Gaetano Giudice 1, Christian H. Ahrens 2, Nicola Zamboni 3 and Gabriella Pessi 1,* ID 1 Department of Plant and Microbial Biology, University of Zurich, CH-8057 Zurich, Switzerland; [email protected] (M.L.); [email protected] (Y.L.); [email protected] (G.G.) 2 Agroscope, Research Group Molecular Diagnostics, Genomics and Bioinformatics & Swiss Institute of Bioinformatics (SIB), CH-8820 Wädenswil, Switzerland; [email protected] 3 Institute of Molecular Systems Biology, ETH Zurich, CH-8093 Zurich, Switzerland; [email protected] * Correspondence: [email protected]; Tel.: +41-44-6352904 Received: 28 February 2018; Accepted: 28 March 2018; Published: 1 April 2018 Abstract: RpoN (or σ54) is the key sigma factor for the regulation of transcription of nitrogen fixation genes in diazotrophic bacteria, which include α- and β-rhizobia.
    [Show full text]
  • The Cosmos with Professor Brian
    The Cosmos with Professor Brian Cox Start time: 8pm Approximate running time: 90 minutes, no interval Please note all timings are approximate and subject to change Programme Jean Sibelius Symphony No 5, mv III (arr Iain Farrington) Charles Ives The Unanswered Question Gustav Mahler Symphony No 10, mv I (arr Michelle Castelletti) Emotion and angst is at the forefront of tonight’s BBC Symphony Orchestra programme, as Harriet Smith explains. Today’s concert, The Cosmos, is inspired by the idea from prominent physicist and broadcaster Brian Cox that music and science are interdependent ways in which we make sense of the world and universe around us. And he should know, for in his earlier days he was keyboard player in the prominent UK bands Dare and D:Ream. So what links tonight’s composers? On the one hand we have Jean Sibelius and Gustav Mahler – two of the most outstanding symphonists of the Romantic tradition – while on the other the American Charles Ives was to all intents and purposes an amateur, albeit a maverick genius. All three were influenced by what was around them in the wider world. In the case of the Finnish Sibelius, we’re lucky enough to have his diaries, which give a real clue into his mindset. While he was working on his Fifth Symphony, his diary of 21 April 1915, rhapsodises: ‘Today at ten to eleven, I saw sixteen swans. One of my greatest experiences! Lord God, what beauty! They circled over me for a long time. Disappeared into the solar haze like a gleaming, silver ribbon.
    [Show full text]
  • Total Signatures
    VOICES FOR CARBON NEUTRALITY Petition Urging Immediate Action on U-M’s Commitment to Carbon Neutrality Faculty + Staff Signatories As of Tuesday, March 3, 2020 Total 1,423 Signatures 512 911 Michigan Medicine Other UM Schools 163 1,256 Students Non-Students 303 794 105 Staff Faculty GSI 79 138 Researchers Other Alex Kime Andy Kirshner Faculty Lecturer Amy Oakley Associate Professor Program on Intergroup Lecturer IV Performing Arts Technology/ A. Galip Ulsoy Relations (IGR) Molecular & Integrative Stamps Distinguished University Physiology Professor Emeritus Alexandra Paige Fischer Ana María León Angel Qin Mechanical Engineering Assistant Professor Assistant Professor Assistant Professor SEAS History of Art, RLL, Internal Medicine A. V. Szot Architecture LEO Intermittent Lecturer Alexandra Vinson Ania Aizman SEAS Assistant Professor Anastasia Hryhorczuk Assistant Professor and Department of Learning Assistant Clinical Professor Postdoctoral Fellow Aaron King Health Sciences of Radiology Slavic Languages and Nelson G. Hairston Literatures Collegiate Professor of Alice Telesnitsky Anatoli Lopatin Ecology, Evolutionary Professor Associate Professor Ann E.Larimore Biology, and Complex Microbiology and MIP Professor Emerita of Systems Immunology Geography and Women’s LSA-EEB, LSA-CSCS Anca Trandafirescu Studies Alison Tribble Associate Professor Residential College and Abigail Jacobs Clinical Assistant Professor Architecture Women’s Studiies Assistant Professor Pediatrics School of Information Andrea Franson Ann Little Allen Hsu Assistant Professor
    [Show full text]
  • A Role for Sigma Receptors in Stimulant Self Administration and Addiction
    Pharmaceuticals 2011, 4, 880-914; doi:10.3390/ph4060880 OPEN ACCESS pharmaceuticals ISSN 1424-8247 www.mdpi.com/journal/pharmaceuticals Review A Role for Sigma Receptors in Stimulant Self Administration and Addiction Jonathan L. Katz *, Tsung-Ping Su, Takato Hiranita, Teruo Hayashi, Gianluigi Tanda, Theresa Kopajtic and Shang-Yi Tsai Psychobiology and Cellular Pathobiology Sections, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, MD, 21224, USA * Author to whom correspondence should be addressed; E-Mail: [email protected]. Received: 16 May 2011; in revised form: 11 June 2011 / Accepted: 13 June 2011 / Published: 17 June 2011 Abstract: Sigma1 receptors (σ1Rs) represent a structurally unique class of intracellular proteins that function as chaperones. σ1Rs translocate from the mitochondria-associated membrane to the cell nucleus or cell membrane, and through protein-protein interactions influence several targets, including ion channels, G-protein-coupled receptors, lipids, and other signaling proteins. Several studies have demonstrated that σR antagonists block stimulant-induced behavioral effects, including ambulatory activity, sensitization, and acute toxicities. Curiously, the effects of stimulants have been blocked by σR antagonists tested under place-conditioning but not self-administration procedures, indicating fundamental differences in the mechanisms underlying these two effects. The self administration of σR agonists has been found in subjects previously trained to self administer cocaine. The reinforcing effects of the σR agonists were blocked by σR antagonists. Additionally, σR agonists were found to increase dopamine concentrations in the nucleus accumbens shell, a brain region considered important for the reinforcing effects of abused drugs.
    [Show full text]
  • Exploring the Activity of an Inhibitory Neurosteroid at GABAA Receptors
    1 Exploring the activity of an inhibitory neurosteroid at GABAA receptors Sandra Seljeset A thesis submitted to University College London for the Degree of Doctor of Philosophy November 2016 Department of Neuroscience, Physiology and Pharmacology University College London Gower Street WC1E 6BT 2 Declaration I, Sandra Seljeset, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I can confirm that this has been indicated in the thesis. 3 Abstract The GABAA receptor is the main mediator of inhibitory neurotransmission in the central nervous system. Its activity is regulated by various endogenous molecules that act either by directly modulating the receptor or by affecting the presynaptic release of GABA. Neurosteroids are an important class of endogenous modulators, and can either potentiate or inhibit GABAA receptor function. Whereas the binding site and physiological roles of the potentiating neurosteroids are well characterised, less is known about the role of inhibitory neurosteroids in modulating GABAA receptors. Using hippocampal cultures and recombinant GABAA receptors expressed in HEK cells, the binding and functional profile of the inhibitory neurosteroid pregnenolone sulphate (PS) were studied using whole-cell patch-clamp recordings. In HEK cells, PS inhibited steady-state GABA currents more than peak currents. Receptor subtype selectivity was minimal, except that the ρ1 receptor was largely insensitive. PS showed state-dependence but little voltage-sensitivity and did not compete with the open-channel blocker picrotoxinin for binding, suggesting that the channel pore is an unlikely binding site. By using ρ1-α1/β2/γ2L receptor chimeras and point mutations, the binding site for PS was probed.
    [Show full text]
  • Phytoalexins: Current Progress and Future Prospects
    Phytoalexins: Current Progress and Future Prospects Edited by Philippe Jeandet Printed Edition of the Special Issue Published in Molecules www.mdpi.com/journal/molecules Philippe Jeandet (Ed.) Phytoalexins: Current Progress and Future Prospects This book is a reprint of the special issue that appeared in the online open access journal Molecules (ISSN 1420-3049) in 2014 (available at: http://www.mdpi.com/journal/molecules/special_issues/phytoalexins-progress). Guest Editor Philippe Jeandet Laboratory of Stress, Defenses and Plant Reproduction U.R.V.V.C., UPRES EA 4707, Faculty of Sciences, University of Reims, PO Box. 1039, 51687 Reims cedex 02, France Editorial Office MDPI AG Klybeckstrasse 64 Basel, Switzerland Publisher Shu-Kun Lin Managing Editor Ran Dang 1. Edition 2015 MDPI • Basel • Beijing ISBN 978-3-03842-059-0 © 2015 by the authors; licensee MDPI, Basel, Switzerland. All articles in this volume are Open Access distributed under the Creative Commons Attribution 3.0 license (http://creativecommons.org/licenses/by/3.0/), which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. However, the dissemination and distribution of copies of this book as a whole is restricted to MDPI, Basel, Switzerland. III Table of Contents About the Editor ............................................................................................................... VII List of
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2003/0171347 A1 Matsumoto (43) Pub
    US 2003.0171347A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0171347 A1 Matsumoto (43) Pub. Date: Sep. 11, 2003 (54) SIGMA RECEPTOR ANTAGONISTS HAVING Publication Classification ANT-COCANE PROPERTIES AND USES THEREOF (51) Int. Cl." ......................... A61K 31/55; A61K 31/33; A61K 31/397; A61K 31/445; (76) Inventor: Rae R. Matsumoto, Edmond, OK (US) A61K 31/40; A61K 31/137 (52) U.S. Cl. .............. 514/183; 514/210.01; 514/217.12; Correspondence Address: 514/317; 514/408; 514/649 DUNLAP, CODDING & ROGERS PC. PO BOX 16370 OKLAHOMA CITY, OK 73114 (US) (57) ABSTRACT (21) Appl. No.: 10/178,859 The present invention relates to novel Sigma receptor antagonist compounds that have anti-cocaine properties. (22) Filed: Jun. 21, 2002 These Sigma receptor antagonists are useful in the treatment Related U.S. Application Data of cocaine overdose and addiction as well as movement disorders. The Sigma receptor antagonists of the present (63) Continuation of application No. 09/715,911, filed on invention may also be used in the treatment of neurological, Nov. 17, 2000, now abandoned, which is a continu psychiatric, gastrointestinal, cardiovascular, endocrine and ation of application No. 09/316,877, filed on May 21, immune System disorders as well as for imaging procedures. 1999, now abandoned. The present invention also relates to novel pharmaceutical compounds incorporating Sigma receptor antagonists which (60) Provisional application No. 60/086,550, filed on May can be used to treat overdose and addiction resulting from 21, 1998. the use of cocaine and/or other drugs of abuse.
    [Show full text]
  • The Pharmacologist December
    Vol. 55 Number 4 2013 The Pharmacologist December Also in this issue: • 2013 Year in Review • 2013 Contributors • 2014 Election Nominees • Program grid for ASPET Annual Meeting at EB 2014 • Holiday Gift Ideas for Pharmacologists • Meet the 2014 Washington Fellows • MAPS Chapter Meeting abstracts (online only) Katharine Dexter McCormick (Courtesy of the Santa Barbara Historical Museum) The Pharmacologist is published and distributed by the American Society for Pharmacology and Experimental Therapeu cs. Contents THE PHARMACOLOGIST PRODUCTION TEAM NEWS Gary Axelrod President's Corner 193 Suzie Thompson Judith A. Siuciak, Ph.D. 2013 Year in Review 194 Richard Dodenhoff 2013 Contributors 196 Danielle Jordan 2013 Corporate Contributors 197 COUNCIL 2014 Elec on Nominees 198 President Richard R. Neubig, M.D., Ph.D. ASPET Annual Mee ng at EB 2014 President-Elect Program Grid 200 Anne e E. Fleckenstein, Ph.D. Past President Important Dates, Informa on, and Links 202 John S. Lazo, Ph.D. Holiday Gi s for Pharmacologists 204 Secretary/Treasurer Sandra P. Welch, Ph.D. FEATURE Secretary/Treasurer-Elect Katharine Dexter McCormick and the Pill Paul A. Insel, M.D. by Rebecca J. Anderson, Ph.D. 206 Past Secretary/Treasurer Edward T. Morgan, Ph.D. DEPARTMENTS Councilors Journals 214 Charles P. France, Ph.D. Science Policy 215 John D. Schuetz, Ph.D. Kenneth E. Thummel, Ph.D. Social Media 221 Chair, Board of Publica ons Trustees Book Review: S ff : The Curious Lives of Human Cadavers 222 James E. Barre , Ph.D. Chair, Program Commi ee In the Spotlight: Interviews with ASPET Members 223 Sco Waldman, M.D., Ph.D.
    [Show full text]
  • Samar Hasnain
    Crystallography,working,across,na2ons, , 1948, Samar Hasnain Volume!68! Acta!Crystallographica!launched! (January,2012)! Founding,editor:,P.P.,Ewald, Max Perutz Professor of Molecular Biophysics, University of Liverpool, UK Editor-in-Chief of IUCr journals 66 years ! & Founding Editor of Journal of Synchrotron Radiation 2014, Volume!69,!Part!1!(January,2013)! IUCrJ -100 years 100 years of from FIRST Crystallography, Nobel prize to Crystallography, [email protected] & [email protected]! IUCr facts 53#member!countries! 42#Adhering!Bodies!(including!4 Regional!Associates:!ACA,!AsCA,!ECA,!LACA)! 23#Commissions! 9#Journals!(including#IUCrJ#launched!in!2014)! IUCr!Congress!every!3#years!(24th IUCr!Congress,!Hyderabad,!August!2017)! Michele Zema The IUCr is a member of since 1947 Project Manager for IYCr2014 EMC5, Oujda, Oct 2013 IUCr Journal milestones 1968, Acta!Crystallographica!split!into!! 1948, SecMon!A:!FoundaMons!of!! Acta!Crystallographica!launched! Crystallography!and!SecMon!B:!! Founding,editor:,P.P.,Ewald, Structural!Science! Founding,editor:,A.J.C.,Wilson, ! 1983, 1968, Acta!Crystallographica!SecMon!C:!! Journal!of!Applied!Crystallography! Crystal!Structure!CommunicaMons!! 1991, launched! Adop2on,of,CIF, launched! Founding,editor:,A.,Guinier, Founding,editor:,S.C.,Abrahams, ! ! 1994, 1993, Journal!of!Synchrotron!! Acta!Crystallographica!SecMon!D:!! RadiaMon!launched! 1999, Biological!Crystallography! Founding,editors:,, Online,, launched! S.S.,Hasnain,,J.R.,Helliwell,, access, Founding,editor:,J.P.,Glusker, and,H.,Kamitsubo,
    [Show full text]
  • Neuropharmacology and Toxicology of Novel Amphetamine-Type Stimulants
    Neuropharmacology and toxicology of novel amphetamine-type stimulants Bjørnar den Hollander Institute of Biomedicine, Pharmacology University of Helsinki Academic Dissertation To be presented, with the permission of the Medical Faculty of the University of Helsinki, for public examination in lecture hall 2, Biomedicum Helsinki 1, Haartmaninkatu 8, on January 16th 2015 at 10 am. Helsinki 2015 Supervisors Thesis committee Esa R. Korpi, MD, PhD Eero Castrén, MD, PhD Institute of Biomedicine, Pharmacology Neuroscience Center Faculty of Medicine University of Helsinki P.O. Box 63 (Haartmaninkatu 8) P.O. Box 56 (Viikinkaari 4) 00014 University of Helsinki, Finland 00014 University of Helsinki, Finland Esko Kankuri, MD, PhD Sari Lauri, PhD Institute of Biomedicine, Pharmacology Neuroscience Center and Faculty of Medicine Department of Biosciences/ Physiology P.O. Box 63 (Haartmaninkatu 8) University of Helsinki 00014 University of Helsinki, Finland P.O.Box 65 (Viikinkaari 1) 00014 University of Helsinki, Finland Reviewers Dissertation opponent Atso Raasmaja, Professor, PhD Prof David Nutt DM FRCP FRCPsych Division of Pharmacology and FMedSci Pharmacotherapy Edmond J. Safra Chair of Faculty of Pharmacy Neuropsychopharmacology P. O. Box 56 (Viikinkaari 5E) Division of Brain Sciences 00014 University of Helsinki, Finland Dept of Medicine Imperial College London Petri J. Vainio, MD, PhD Burlington Danes Building Pharmacology, Drug Development and Hammersmith Hospital Therapeutics Du Cane Road Institute of Biomedicine London W12 0NN, United Kingdom Faculty of Medicine Kiinamyllynkatu 10 C 20014 University of Turku, Finland The cover layout is done by Anita Tienhaara. The cover photo is by Edd Westmacott and shows a close-up of ecstasy tablets, photographed in Amsterdam in 2004.
    [Show full text]